Obagi-C Rx Night Cream Recalled for Missing Safety Information
Valeant Pharmaceuticals is recalling 844 bottles of Obagi-C Rx System C-Therapy Night Cream because the bottles are missing the product insert and outer carton containing safety instructions.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/packaging defect rather than a direct physical hazard.
Plain-English summary
Valeant Pharmaceuticals North America LLC is recalling 844 bottles of Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g). The product is distributed by OMP, Inc. in Long Beach, CA, and was distributed nationwide in the United States. The specific lot number is 2578400, with an expiration date of 8/2019.
The recall was initiated due to incomplete packaging and labeling. The bottles are missing the product insert and the outer carton, which contain the complete instructions for use and safety information. The FDA has classified this recall as Class III, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return the product.
The recalled product
- Product
- Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Category
- Drug — Topical Prescription
- Hazard
- Affected units
- 844
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2578400
- 0Exp 8/2019
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Valeant Pharmaceuticals North America LLC
See all →- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- LowValeant Recalls Diltiazem HCl Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
Same hazard · missing labeling
See all →- ModerateBadger 50 Mineral Sunscreen Recalled for Missing Drug Facts Labeling
FDA (Drugs) · 2025-02-05
- HighSour Charlie bread recalled for undeclared wheat allergen
FDA (Food) · 2024-10-30
- HighImpella CP Smart Assist Set Lacks Labeling for Potential Device Interaction
FDA (Devices) · 2024-09-11
- ModerateImpella CP Smart Assist Set: Device interaction safety labeling update
FDA (Devices) · 2024-09-11
- HighImpella 5.5 Pump Labeling Updated Due to Device Interaction
FDA (Devices) · 2024-09-11